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Background: Heart rate variability (HRV) and heart rate (HR) dynamics are used to
predict the survival probability of patients after acute myocardial infarction (AMI), but the
association has been established in patients with mixed levels of left ventricular ejection
fraction (LVEF).
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Objective: We investigated whether the survival predictors of HRV and HR dynamics
depend on LVEF after AMI.
Methods: We studied 687 post-AMI patients including 147 with LVEF ≤35% and 540
with LVEF >35%, of which 23 (16%) and 22 (4%) died during the 25 month followup period, respectively. None had an implanted cardioverter-defibrillator. From baseline
24 h ECG, the standard deviation (SDNN), root mean square of successive difference
(rMSSD), percentage of successive difference >50 ms (pNN50) of normal-to-normal
R-R interval, ultra-low (ULF), very-low (VLF), low (LF), and high (HF) frequency power,
deceleration capacity (DC), short-term scaling exponent (α1 ), non-Gaussianity index
(λ25s ), and the amplitude of cyclic variation of HR (Acv) were calculated.
Results: The predictors were categorized into three clusters; DC, SDNN, α1 , ULF, VLF,
LF, and Acv as Cluster 1, λ25s independently as Cluster 2, and rMSSD, pNN50, and HF
as Cluster 3. In univariate analyses, mortality was best predicted by indices belonging
to Cluster 1 regardless of LVEF. In multivariate analyses, however, mortality in patients
with low LVEF was best predicted by the combinations of Cluster 1 predictors or Cluster
1 and 3 predictors, whereas in patients without low LVEF, it was best predicted by the
combinations of Cluster 1 and 2 predictors.
Conclusion: The mortality risk in post-AMI patients with low LVEF is predicted by
indices reflecting decreased HRV or HR responsiveness and cardiac parasympathetic
dysfunction, whereas in patients without low LVEF, the risk is predicted by a combination
of indices that reflect decreased HRV or HR responsiveness and indicator that reflects
abrupt large HR changes suggesting sympathetic involvement.
Keywords: heart rate dynamics, heart rate variability, myocardial Infarction, mortality, redundancy, risk
stratification, survival, left ventricular ejection fraction
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HR responsiveness to apneic episodes during sleep. It quantifies
the shortening in cardiac cycles caused by sleep-apnea-induced
transient arousals. Because this HR response is abolished by
atropine (Zwillich et al., 1982; Guilleminault et al., 1984), Acv is
thought to reflect a reflex parasympathetic function. The tonic
and reflex parasympathetic dysfunction is believed to be a risk
for post-AMI mortality (Camm et al., 1996; Bauer et al., 2006;
Hayano et al., 2017) because parasympathetic antagonism against
sympathetic activation is important to maintain ventricular
myocardial electric stability and to prevent the development
of fatal ventricular arrhythmias (Hull et al., 1990, 1994;
La Rovere et al., 1998).
The frequency-domain indices of HRV are calculated by the
power spectral analysis of N-N interval time series and are
quantified as the power of frequency components. Among such
components, ultra-low frequency (<0.0033 Hz; ULF) and verylow-frequency (0.0033–0.04 Hz; VLF) components reflect fractallike HR fluctuation that accounts for most of the power of 24 h
HRV (Saul et al., 1988). A reduction in the VLF power is one
of the most powerful predictors of post-AMI mortality (Bigger
et al., 1992). In contrast, a reduction in the high-frequency
component (HF, 0.15–0.40 Hz), which is thought to reflect
cardiac parasympathetic dysfunction, paradoxically shows the
lowest predictive power (Bigger et al., 1992). This paradox may be
explained at least partly by the contamination of non-autonomic
high-frequency R-R interval fluctuations caused by heart rate
fragmentation (Costa et al., 2017; Hayano et al., 2020), which is a
type of pacemaker dysfunction more likely to appear in high-risk
patients (Costa et al., 2018).
The HR dynamics reflect the non-linear properties of HR
fluctuation. Detrended fluctuation analysis (Peng et al., 1995)
quantifies the scaling exponents of fractal-like HR dynamics and
a reduction in the short-term (4–11 beats) scaling exponent (α1 )
is increased risk for post-AMI mortality (Huikuri et al., 2000).
The non-Gaussianity index (λ) quantifies the probability density
function for abrupt large HR changes suggesting sympathetic
involvement (Kiyono et al., 2007). The λ is increased in patients
with heart failure, known as the state of increased sympathetic
activity, while other HRV indices are decreased (Kiyono et al.,
2007). Additionally, λ is lower in these patients taking betablocker than in those without taking beta-blocker (Kiyono et al.,
2007). An increase in λ calculated at a time scale of 25 s
(λ25s ) predicts increased risk for post-AMI cardiac mortality
(Hayano et al., 2011a).
In the present study, we hypothesized that the HRV and
HR dynamics indices and their combinations to predict postAMI mortality risk differ between patients with and without
low LVEF (≤35%). Most of earlier studies reporting predictive
power of HRV and HR dynamics were conducted in postAMI patients with mixed levels of LVEF (Kleiger et al., 1987;
Bigger et al., 1992; Zuanetti et al., 1996; Lanza et al., 1998;
Huikuri et al., 2000; Hayano et al., 2011a). The risk stratification
models developed by the earlier studies may need to be
reappraised separately depending on LVEF. The prophylactic
ICD in post-AMI patients with low LVEF could also modify
the risk structures. Considering these factors, we chose 24 h
ECG data from the post-AMI cohort collected before ICD

INTRODUCTION
Despite significant achievements in its clinical management
(Antman et al., 2004), acute myocardial infarction (AMI) remains
a leading cause of death (Virani et al., 2020). AMIs occur in
the United States at a rate of 1 person every 40 s, with an
associated mortality of approximately 110,000 per year (Virani
et al., 2020). Sudden cardiac death (SCD) is the most common
cause of death after AMI (Zaman and Kovoor, 2014), and patients
with a low left ventricular ejection fraction (LVEF) are at the
highest risk of SCD during the early months to years after
AMI (Solomon et al., 2005; Adabag et al., 2008). To prevent
SCD, prophylactic implantation of cardioverter-defibrillators has
been recommended for post-AMI patients with LVEF ≤35%
(Moss et al., 2002; Goldberger and Lampert, 2006). However,
the generalization of reperfusion therapy early after AMI onset
(Aversano et al., 2002) has reduced the proportion of postAMI patients with low LVEF, and consequently, the majority of
SCDs occur in patients with LVEF >35%. It has become more
important to find clinical markers to predict an increased risk
of death in patients without low LVEF (Arevalo et al., 2016). In
this study, we analyzed heart rate variability (HRV) and heart
rate (HR) dynamics in post-AMI patients to determine the useful
markers and combinations to predict mortality risk separately
between patients with LVEF ≤35% and those with LVEF >35%.
The analysis of HRV and HR dynamics are widely used
for survival risk stratification in cardiovascular diseases (Camm
et al., 1996), particularly after AMI (Kleiger et al., 1987;
Bigger et al., 1992; Peng et al., 1995; La Rovere et al., 1998;
Huikuri et al., 2000; Bauer et al., 2006; Kantelhardt et al.,
2007; Kiyono et al., 2007, 2008; Hayano et al., 2011a, 2017;
Watanabe et al., 2016). The R-R interval time series data
obtained from the 24 h Holter ECG are mainly used for
these analyses and many indices have been proposed. The
HRV indices are classified into time-domain and frequencydomain indices (Camm et al., 1996). The time-domain indices
include the statistical measures of normal-to-normal (N-N)
interval (R-R interval of consecutive sinus rhythms) variation,
such as the standard deviation of 24 h N-N interval (SDNN)
(Kleiger et al., 1987), root mean square of successive N-N
interval difference (rMSSD), percentage of successive N-N
intervals differing >50 ms (pNN50), deceleration capacity (DC)
(Kantelhardt et al., 2007), and the amplitude of cyclic variation
of HR (Acv) (Hayano et al., 2011b). Among these, rMSSD and
pNN50 that quantify high-frequency N-N interval fluctuations
reflect the tonic or sustained level of cardiac parasympathetic
control (Berntson et al., 1997; Laborde et al., 2017). Due to
a low-pass filter-like-transfer function, the sympathetic HR
control cannot involve the modulation of these high-frequency
fluctuations (Berger et al., 1989), and thus, these fluctuations
are mediated purely by the vagus. In contrast, Acv reflects the
Abbreviations: Acv, amplitude of cyclic variation of heart rate; ALLSTAR,
Allostatic State Mapping by Ambulatory ECG Repository; AMI, acute myocardial
infarction; DC, deceleration capacity; ENRICHD, Enhancing Recovery in
Coronary Heart Disease; Fcv, frequency of cyclic variation of heart rate; HR, heart
rate; HRF, heart rate fragmentation; HRV, heart rate variability; SDNN, standard
deviation of normal-to-normal R-R interval; VLF, very low frequency.
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became clinically widespread and we compared the HRV and
HR dynamics indices associated with mortality risk between
patients with and without low LVEF. Furthermore, considering
the possible redundancy existing among the indices of HRV and
HR dynamics (Yuda et al., 2020), we categorized the indices into
classes by cluster analysis and analyzed the class-relationships
with mortality risk.

Data Analysis
The time-domain and frequency-domain indices of HRV and
the non-linear indices of HR dynamics that are known as
major predictors of post-AMI mortality were calculated by the
methods according to the recommended standard (Camm et al.,
1996) and to previously published studies (Peng et al., 1995;
Iyengar et al., 1996; Kantelhardt et al., 2007; Kiyono et al., 2007;
Hayano et al., 2017).
Briefly, the time series of N-N intervals were derived from
24 h ECG data. For the time domain HRV indices, SDNN was
computed as the 24 h standard deviation of N-N intervals, rMSSD
was calculated as the square root of the mean square of 24 h
successive N-N interval differences, pNN50 was obtained as the
percentage of successive N-N intervals differing >50 ms, and DC
was computed by the phase rectified signal averaging of the 24
h N-N interval time series (Kantelhardt et al., 2007). Acv was
calculated by signal-averaging the amplitude of cyclic variation
of HR detected by the method of auto-correlated wave detection
with adaptive threshold algorithm (Hayano et al., 2011b).
For the frequency domain index, the N-N interval power
spectrum was computed by a Fast Fourier transform with a
Hanning window after interpolating with a horizontal step
function and resampling at 2 Hz. The power spectral density
was integrated for the power within the ULF (<0.0033 Hz),
VLF (0.0033–0.04 Hz), LF (0.04–0.15 Hz), and HF (0.15–
0.4 Hz) bands, respectively, and transformed into natural
logarithmic values.
For the non-linear indices, the fractal correlation properties
of HR dynamics were computed using the detrended fluctuation
analysis and measured as the short-term (4–11 beat) scaling
exponents (α1 ) (Peng et al., 1995; Iyengar et al., 1996). Also,
the non-Gaussianity index of λ was calculated at a time scale
of 25 s (λ25s ) according to our previous work (Hayano et al.,
2011a). This analysis detects the intermittency of HR increment.
The intermittent behavior of HRV is related to non-Gaussian
probability distribution with marked fat tails and a peak around
the mean value, indicative of a higher probability of the
interspersed appearance of large and small increments than the
Gaussian fluctuations. The λ quantifies the fatness of the tails
of the non-Gaussian probability distribution. The mathematical
description of the non-Gaussianity index has been reported
elsewhere (Kiyono et al., 2004, 2007).

MATERIALS AND METHODS
Study Cohort
We examined retrospective cohort data from a subset of the
Enhancing Recovery in Coronary Heart Disease (ENRICHD)
study (Berkman et al., 2003) consisting of 687 patients who
had an AMI and were admitted to the coronary care units of 4
of the 8 ENRICHD clinical trial sites (Washington University,
St. Louis, Missouri; Duke University, Durham, North Carolina;
Harvard University, Boston, Massachusetts; Yale University,
New Haven, Connecticut) between October 1997 and January
2000. The sample included 327 participants of the ENRICHD
clinical trial who scored 10 or higher on the Beck Depression
Inventory (Beck, 1972) and 360 AMI control participants who
were not randomized in the ENRICHD trial because they
were not depressed, but were otherwise medically eligible
for the trial. Patients were included if they had analyzable
Holter ECG data >20.4 h (85% of 24 h) including >3 h of
sleep period (time in bed). Patients were excluded if they:
(1) had other life-threatening illnesses; (2) were too ill or
logistically unable to participate; (3) had ECG data in sinus
rhythm <80% of total recorded beats, or (4) had atrial fibrillation,
atrial flutter, or an implanted pacemaker or defibrillator.
The collection and analysis of Holter ECG recordings were
approved by the ethics committees of the corresponding clinical
sites. All participants provided written informed consent to
participate in the study.
The end-point of the present study was all-cause mortality.
Patients underwent follow-up assessments 6 months after study
enrollment and annually thereafter for up to 30 months. The
end-points were identified from follow-up visits, telephone
calls, routine hospital surveillance, and contacts with patients’
physicians. The records of every identified hospitalization were
obtained for review and confirmation by a panel of physicians.
Death certificates were obtained for all reported deaths. The
mortality endpoints used for the present study were either cardiac
deaths (AMI, cardiac failure, and sudden cardiac death) or noncardiac deaths.

Cluster Analysis of HRV and HR
Dynamics Indices
To categorize HRV and HR dynamics indices, a cluster analysis
was performed based on the correlation matrix between the
indices. We used a divisive type cluster analysis. The analysis
started with the assumption that all indices belong to a single
cluster and continued to divide clusters until the eigenvalue
of the second principal component of all clusters becomes
less than 1. The cluster to which the index belongs was
determined from the factor structure of the oblique principal
component so that the index was classified into the clusters
where the first principal component gives the highest correlation
coefficient with the index.

Measurements
Holter ECGs were recorded for 24 h within 28 [median (IQR),
13 (6–19)] days after the index AMI. The ECG recordings
were scanned at the Heart Rate Variability Core laboratory
at Washington University on a Marquette SXP Laser scanner
with software version 5.8 (Marquette Electronics) using standard
procedures. The annotated beat file was exported to a workstation
for analysis of HRV and HR dynamics indices.
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1, λ25s independently as Cluster 2, and rMSSD, pNN50, and
HF as Cluster 3.

Evaluation of Predictive Performance
The predictive performance of the discriminant models,
including those consisting of a single index and those of
the combinations of multiple indices, was analyzed by logistic
regression and evaluated by Somers’ D and c-statistic. The logistic
regression model provided prediction scores for individual
participants and compared the scores between all possible pairs
of survivors and non-survivors. Pairs with a survivor score higher
than non-survivors were considered concordant, otherwise, they
were considered discordant. Somers’ D was calculated as the
difference between the number of concordant and discordant
pairs divided by the number of all possible pairs, taking a value
from -1 (all pairs disagree) to 1 (all pairs agree). The c-statistic
reflected the area under the receiver-operating characteristic
curve for the predictive performance of the regression models.

Univariate Associations of HRV and HR
Dynamics With Post-AMI Mortality
Table 2 shows the difference in HRV and HR dynamic indices
between survivors and non-survivors. Regardless of LVEF, nonsurvivors had lower values for all indices in Cluster 1. Among
patients with low LVEF, non-survivor has lower HF in Cluster 3,
but λ25s (Cluster 2) did not differ significantly between survivors
and non-survivors. Among patients without low LVEF, nonsurvivors had greater λ25s (Cluster 2), and lower values for all
indices in Cluster 3.
Table 3 shows the results of the univariate logistic regression
analysis. Regardless of LVEF, the top five predictors based on the
c-statistic belonged to Cluster 1.

Statistical Analysis

Multivariate Associations of HRV and HR
Dynamics With Post-AMI Mortality

We used SAS version 9.4 programs (SAS Institute, Cary, NC).
Differences between survivors and non-survivors were evaluated
by the Chi-square test for categorical data and by Wilcoxon twosample test for continuous data. The SAS VARCLUS procedure
with an oblique principal component cluster analysis was used
to categorize the HRV and HR dynamics indices. The SAS
LOGISTIC procedure was used for the logistic regression analysis
for mortality risk stratification by HRV and HR dynamics
indices and their combinations. All models included age as an
independent predictor. For all statistical analyses, P < 0.05 was
considered significant.

Table 4 shows the results of logistic regression analyses for
all combinations between two predictors. Among patients with
low LVEF, the top five performances were observed with
the combinations between two predictors both in Cluster 1
and the combination between Cluster 1 and 3 predictors.
In contrast, among patients without low LVEF, the top five
performances were observed with the combinations between
Cluster 1 and 2 predictors.
These features were also observed for the prediction models
consisting of three predictors (Table 5). The mortality in patients
with low LVEF was best predicted by the combinations of Cluster
1 and 3 predictors. In patients without low LVEF, the top four
performances were observed with the combinations between
Cluster 1 and 2, although the combinations of Cluster 1, 2, and
3 predictors also showed the 4th best performance.

RESULTS
Patients’ Characteristics
Patient characteristics are presented in Table 1. With baseline
LVEF, the participants were divided into 147 patients with
LVEF ≤35% (low LVEF) and 540 patients with LVEF >35%.
During the follow-up period, 23 (16%) patients with low LVEF
and 22 (4%) patients without low LVEF died from all-causes.
Among patients with low LVEF, non-survivors were more often
diabetic and mentally depressed, had lower LVEF, and had higher
serum creatinine. Survivors were more likely to have had more
frequent coronary angioplasty. Among patients without low
LVEF, non-survivors were older and more often diabetic and
smoker, had more frequent histories of coronary bypass surgery,
had lower LVEF, had higher serum creatinine, and were more
often Killip class III-IV after the index AMI. Survivors were more
likely to have had an index AMI of the inferior wall and had more
frequent acute reperfusion after the AMI.

DISCUSSION
In this study, we sought to determine if HRV and HR dynamics
indices that predict mortality risk after AMI differ between
patients with and without low LVEF (≤35%). Considering the
possible redundancy existing among HRV and HR dynamics
indices (Yuda et al., 2020), we first categorized the predictors
into classes. The cluster analysis revealed that the predictors can
be classified into 3 clusters thought to reflect the magnitude
of HRV or HR responsiveness (Cluster 1: DC, SDNN, α1 ,
ULF, VLF, LF, and Acv), the frequency of abrupt large HR
changes (Cluster 2: λ25s ), and cardiac parasympathetic function
(Cluster 3: rMSSD, pNN50, and HF), respectively. Then, we
examined the associations between clustered predictors and
mortality risk in patients with and without low LVEF, separately.
Univariate analyses showed that mortality was best predicted
by indices belonging to Cluster 1 regardless of LVEF, but
multivariate analyses showed that mortality in patients with low
LVEF was best predicted by the combinations of two Cluster
1 predictors or Cluster 1 and 3 predictors, while in patients
without low LVEF, it was best predicted by the combinations

Cluster Analysis of HRV and HR
Dynamics Indices
Figure 1 shows the tree diagram of the hierarchical cluster based
on the principal component of the correlation matrix. The cluster
analysis was performed in all 687 patients without separating
with LVEF. The predictors were found to be categorized into
three clusters; DC, SDNN, α1 , ULF, VLF, LF, and Acv as Cluster
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TABLE 1 | Patients’ characteristics.
LVEF >35%

LVEF ≤35%
Survivor

Non-survivor

Survivor

Non-survivor

124 (84%)

23 (16%)

518 (96%)

22 (4%)

778 (590–1,024)

499 (175–657)

0 (0%)

18 (78%)

769 (574–974)

373 (203–696)

0 (0%)

14 (64%)

62 (53–71)

63 (53–75)

37 (30%)

10 (43%)

0.3

58 (49–67)

69 (59–71)

0.001

0.1

215 (42%)

10 (45%)

27.6 (24.5–31.2)

0.7

28.3 (24.0–35.0)

0.6

28.5 (25.4–32.1)

28.4 (26.2–32.4)

Hypertension

0.6

21 (17%)

4 (17%)

0.9

107 (21%)

8 (36%)

0.05

Diabetes mellitus

32 (26%)

15 (65%)

0.0002

128 (25%)

17 (77%)

Current smoker

38 (31%)

4 (17%)

0.2

189 (36%)

3 (14%)

0.03

BDI score ≥10

52 (42%)

18 (78%)

0.001

243 (47%)

14 (64%)

0.1

History of myocardial infarction

39 (31%)

11 (48%)

0.1

90 (17%)

7 (32%)

History of coronary bypass surgery

22 (18%)

7 (30%)

0.1

42 (8%)

7 (32%)

Number of patients, n

P*

P*

Outcome
Follow-up (days), median (IQR)
Cardiac death

<0.0001

<0.0001

Demographic and clinical
Age (years), median (IQR)
Women
Body mass index (kg/m2 ), median (IQR)

LVEF (%), median (IQR)

30 (26–35)

25 (20–30)

1.0 (0.8–1.2)

1.3 (1.1–2.3)

Killip class III-IV

15 (12%)

5 (22%)

Anterior wall AMI

68 (55%)

9 (39%)

Inferior wall AMI

42 (34%)

β-Blockers
Angiotensin converting enzyme inhibitors
Aspirin

Creatinine (mg/dL), median (IQR)

<0.0001

0.1
<0.0001

0.0007

52 (45–55)

45 (40–52)

0.01

<0.0001

1.0(0.8–1.1)

1.2 (0.9–2.1)

0.01

0.2

15 (3%)

3 (14%)

0.003

0.2

141 (27%)

4 (18%)

0.4

5 (22%)

0.3

258 (50%)

5 (23%)

0.01

101 (81%)

17 (74%)

0.3

424 (82%)

20 (91%)

0.2

90 (73%)

16 (70%)

0.7

222 (43%)

11 (50%)

0.5

110 (89%)

17 (74%)

0.05

476 (92%)

17 (77%)

0.01

Index AMI

Treatment

Calcium channel blockers

12 (10%)

3 (13%)

0.6

74 (14%)

7 (32%)

0.02

Thrombolytic therapy after AMI

38 (31%)

6 (26%)

0.7

173 (33%)

2 (9%)

0.02

Coronary bypass after AMI

27 (22%)

1 (4%)

0.05

73 (14%)

2 (9%)

0.5

Coronary angioplasty
<24 h after AMI

66 (53%)

4 (17%)

0.004

334 (64%)

12 (55%)

0.2

Acute reperfusion < = 12 h after AMI

55 (44%)

6 (26%)

0.1

250 (48%)

5 (23%)

0.02

*Significance of difference by Wilcoxon two sample test for continuous variables and by chi-square test for categorical variables. AMI, acute myocardial infarction; LVEF, left
ventricular ejection fraction.

DC had greater predictive power than SDNN and LVEF and
reported that the risk stratification by DC was more useful in
patients with LVEF >30% than in those with LVEF ≤30%. Liu
et al. (2020) recently reported that decreased SDNN, VLF, and
DC were independently associated with increased risk of sudden
arrhythmic death in post-AMI patients with LVEF ≤35% and
that combination of SDNN, VLF, and DC may help identify
a high-risk patient group. Lombardi et al. (1996) compared
HRV and HR dynamics indices between post-AMI patients
with and without low LVEF and they observed reduced HRV
power in the entire frequency range in patients with low
LVEF, suggesting diminished responsiveness of sinus node to
autonomic modulatory inputs in these patients. None of these
studies, however, reported the difference in predictors between
post-AMI patients with and without low LVEF.
In this study, we used retrospective cohort data of the
ENRICHD study. The patients of this cohort had an AMI and
admitted hospital between October 1977 and January 2000.
Therefore, the fraction of patients who received a primary
percutaneous coronary intervention was low and none of them

of Cluster 1 and 2 predictors. Our findings indicate that
the mortality risk in post-AMI patients with low LVEF is
predicted by decreased HRV or HR responsiveness and cardiac
parasympathetic dysfunction, whereas in patients without low
LVEF, the risk is predicted by a combination of decreased HRV
or HR responsiveness and increased abrupt large HR changes
suggesting sympathetic involvement.
To our knowledge, this is the first study to compare HRV
and HR dynamics indices that predict mortality between postAMI patients with and without low LVEF. Most of earlier studies
reporting predictive power of HRV and HR dynamics were
conducted in post-AMI patients with mixed levels of LVEF,
although they reported the independence of the predictive power
of the indices from LVEF (Kleiger et al., 1987; Bigger et al.,
1992; Zuanetti et al., 1996; Lanza et al., 1998; Hayano et al.,
2011a). Also, Huikuri et al. (2000) examined the predictive
value of HRV and HR dynamics in post-AMI patients with
LVEF ≤35% and reported that a decrease in α1 had greater
predictive power of post-AMI mortality than conventional HRV
indices. Bauer et al. (2006) demonstrated that a decrease in
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FIGURE 1 | Cluster analysis of HRV and HR dynamics indices in post-AMI patients. DC, deceleration capacity; SDNN, standard deviation of normal-to-normal R-R
interval during 24 h; ULF, power of ultra-low-frequency (<0.0033 Hz) component; VLF, power of very-low-frequency (0.0033–0.04 Hz) component; LF, power of
low-frequency (0.04–0.15 Hz) component; Acv, amplitude of the cyclic variation of heart rate; λ25s , non-Gaussianity index for a segment length of 25 s; Fcv,
frequency of the cyclic variation of heart rate; rMSSD, root mean square of successive R-R interval differences; pNN50, percentage of successive R-R intervals
differing >50 ms, and HF, power of high-frequency (0.15–0.40 Hz) component.

Second, the observation that all of the top five univariate
predictors of post-AMI mortality belonged to Cluster 1 regardless
of LVEF indicates the prognostic significance of the feature(s)
common to the indices of this cluster. Although Cluster
1 includes a variety of indices, they commonly reflect the
magnitude of HRV, such as SDNN, ULF, VLF, and LF, which
are thought to be mediated by interactions between sympathetic
and parasympathetic nerve activities, although parasympathetic
dysfunction has been thought to be a primary cause of decreased
HRV at rest and during sleep (Camm et al., 1996). Earlier
studies reported that 92% of VLF power was suppressed by high
dose atropine (0.04 mg/kg) (Taylor et al., 1998). DC has been
developed to measure the rapid increase in R-R intervals caused
only by parasympathetic control (Kantelhardt et al., 2007). The
α1 increases with atropine and decreases with parasympathetic
activation (Tulppo et al., 2001, 2005), although it decreases with
increased levels of circulating noradrenaline in healthy men
(Tulppo et al., 2001) and increases with β-blocker therapy in
patients with heart failure (Lin et al., 2001; Ridha et al., 2002).
Acv is thought to reflect a reflex parasympathetic function and
its decrease indicates blunted parasympathetic responses to sleep
apnea episodes (transient hypoxia, arousal, etc.) (Hayano et al.,
2017). Acv is almost completely abolished by 2 mg of intravenous
atropine but is unchanged by 5 mg of intravenous propranolol

had an ICD. We chose this cohort to allow comparison of postAMI patients without low LVEF with a sufficiently sized group
of patients with low LVEF whose survival risk is not affected
by a prophylactic ICD. Additionally, the sample of this study
included a subset of patients enrolled in the ENRICHD trial
who had elevated symptoms of depression, which could affect
the generalizability of our results. However, the proportion of
the depressed patients with BDI scores ≥10 was 47.5%, which is
comparable to the reported prevalence of depression (45–47%) in
general post-AMI populations (Schleifer et al., 1989; Steeds et al.,
2004).
We performed a cluster analysis of HRV and HR dynamics
indices in the entire cohort of post-AMI patients. The indices
were classified into three clusters and we observed that the
associations between the HRV and HR dynamics indices
and mortality risk were well explained as class-dependent
relationships. These findings provide several insights into the
underlying mechanisms.
First, the formation of clusters indicates that there are
significant inter-correlations between these indices by the
eigenvalue criteria of principal component analysis, supporting
our previous finding of a big-data study reporting the
substantial redundancy among HRV and HR dynamics indices
(Yuda et al., 2020).
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TABLE 2 | Comparisons of baseline heart rate variability (HRV) and heart rate (HR) dynamics indices between survivors and non-survivors.
Index, median (IQR)

LVEF >35%

LVEF ≤35%
Survivor

Non-survivor

Survivor

P*

Non-survivor

P*

DC (ms)

4.2 (3.1 − 6.2)

2.9 (2.3 − 3.6)

0.0002

5.3 (3.7 − 6.7)

2.7 (2.2 − 3.8)

SDNN (ms)

87 (63 − 109)

56 (47 − 73)

0.0004

90 (69 − 118)

65 (54 − 78)

<0.0001
0.0008

α1

1.2 (0.9 − 1.3)

0.8 (0.6 − 1.1)

0.002

1.2 (1 − 1.3)

0.8 (0.7 − 1.2)

0.001

ULF [ln(ms2 )]

8.6 (7.9 − 9.1)

7.7 (7.3 − 8.3)

0.0005

8.7 (8 − 9.2)

8 (7.6 − 8.4)

VLF [ln(ms2 )]

6.7 (6 − 7.3)

5.7 (4.9 − 6.1)

0.0002

6.8 (6 − 7.5)

5.4 (4.6 − 6.3)

LF[ln(ms2 )]

5.4 (4.3 − 6.4)

4.1 (3.5 − 4.8)

0.0005

5.6 (4.6 − 6.3)

4.7 (2.8 − 5.3)

0.0003

Acv [ln(ms)]

3.9 (3.5 − 4.3)

3.3 (3 − 3.6)

<0.0001

4.2 (3.7 − 4.5)

3.2 (2.9 − 3.7)

<0.0001

λ25s

0.5 (0.5 − 0.7)

0.6 (0.4 − 0.7)

0.7

0.5 (0.5 − 0.6)

0.6 (0.5 − 0.6)

0.002

rMSSD (ms)

20 (14 − 34)

16 (12 − 24)

0.1

23 (16 − 33)

15 (11 − 29)

0.01

pNN50 (%)

2.6 (0.4 − 10.7)

0.8 (0.1 − 4.8)

0.09

3.1 (0.8 − 10.2)

0.5 (0.1 − 6.8)

0.01

HF [ln(ms2 )]

4.4 (3.5 − 5.5)

3.6 (2.9 − 4.5)

0.03

4.6 (3.9 − 5.5)

3.5 (3 − 5.2)

0.009

0.001
<0.0001

*Significance of difference by Wilcoxon two sample test. Abbreviations are explained in the legend of Figure 1.

TABLE 3 | Predictive power of HRV and HR dynamics indices for post-AMI mortality (logistic regression analysis).
Predictor

LVEF >35%

LVEF ≤35%
Concordant,%

Discordant,%

Somers’ D

c-Statistic

Concordant,%

Discordant,%

Somers’ D

c-Statistic

DC

74.4

25.6

0.489

0.744

82.7

17.3

0.655

0.827

SDNN

75.6

24.4

0.512

0.756

77.1

22.9

0.542

0.771

α1

70.0

30.0

0.399

0.700

74.7

25.3

0.493

0.747

ULF

74.1

25.9

0.481

0.741

77.7

22.3

0.553

0.777

VLF

75.4

24.6

0.508

0.754

80.9

19.1

0.618

0.809

LF

74.5

25.5

0.490

0.745

79.1

20.9

0.582

0.791

Acv

80.7

19.3

0.614

0.807

82.5

17.5

0.649

0.825

λ25s

53.5

46.5

0.070

0.535

74.9

25.1

0.497

0.749

rMSSD

56.5

43.5

0.130

0.565

73.3

26.7

0.465

0.733

pNN50

56.6

43.4

0.133

0.566

73.0

27.0

0.461

0.730

HF

65.4

34.6

0.309

0.654

76.8

23.2

0.536

0.768

All classification models are adjusted for the effect of age. Boldface indicates the top five largest c-statistic values for LVEF ≥35% and LVEF >35%, respectively.
Abbreviations are explained in the legend of Figure 1.

TABLE 4 | Predictive performance (c-statistics) of combinations of two predictors among post-AMI patients grouped by LVEF.

DC

DC

SDNN

α1

ULF

VLF

LF

Acv

λ25s

rMSSD

pNN50

HF

–

0.824

0.823

0.825

0.824

0.823

0.830

0.840

0.828

0.830

0.824

0.773

–

0.775

0.778

0.808

0.792

0.824

0.803

0.771

0.772

0.780

α1

0.768

0.773

–

0.782

0.802

0.789

0.816

0.769

0.791

0.792

0.791

ULF

0.743

0.745

0.726

–

0.810

0.800

0.830

0.815

0.782

0.781

0.792

SDNN

VLF

0.758

0.762

0.751

0.754

–

0.809

0.826

0.832

0.808

0.808

0.808

LF

0.765

0.767

0.766

0.742

0.733

–

0.825

0.832

0.790

0.791

0.790

Acv

0.806

0.810

0.811

0.806

0.807

0.816

–

0.836

0.824

0.823

0.826

λ25s

0.728

0.728

0.672

0.739

0.746

0.740

0.807

–

0.801

0.787

0.8327

rMSSD

0.738

0.769

0.730

0.732

0.761

0.773

0.816

0.551

–

0.728

0.769

pNN50

0.740

0.759

0.737

0.741

0.760

0.765

0.817

0.581

0.556

–

0.769

HF

0.738

0.744

0.768

0.732

0.759

0.751

0.808

0.684

0.717

0.699

–

LVEF > 35%

LVEF ≤ 35%
Data are c-statistics calculated by logistic regression analysis. Values in lower left half and upper right half represent those for patients with LVEF ≤35% and those with
LVEF > 35%, respectively. Boldface indicates the top five largest values for LVEF ≤35% and LVEF >35%, respectively. All classification models are adjusted for the effect
of age. Abbreviations are explained in the legend of Figure 1.
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TABLE 5 | Combinations of three predictors with the top five predictive performance.
Best combination

Concordant,%

Discordant,%

Somers’ D

c-Statistic

LVEF ≤35%
α1 + Acv + rMSSD

82.1

17.9

0.641

0.821

Acv + rMSSD + HF

81.8

18.2

0.636

0.818

Acv + rMSSD + pNN50

81.5

18.5

0.629

0.815

SDNN + Acv + rMSSD

81.5

18.5

0.63

0.815

ULF + Acv + rMSSD

81.5

18.5

0.63

0.815

ULF + Acv + λ25s

84.4

15.6

0.689

0.844

VLF + Acv + λ25s

83.7

16.3

0.674

0.837

ULF + VLF + λ25s

83.2

16.8

0.665

0.832

SDNN + VLF + λ25s

83.1

16.9

0.661

0.831

VLF + λ25s + pNN50

83.1

16.9

0.663

0.831

LVEF >35%

All prediction models are adjusted for the effect of age. Abbreviations are explained in the footnote in Table 2.

(Guilleminault et al., 1984). These indicate that decreased HRV
or HR responsiveness mediated primarily by parasympathetic
dysfunction is the most important single feature associated with
mortality risk in post-AMI patients with and without low LVEF.
Third, the observation that mortality risk in patients with low
LVEF was best predicted by the combinations of indices both in
Cluster 1 or those in Cluster 1 and 3 indicates an increased risk
of the coexistence of tonic/sustained and reflex parasympathetic
disfunction. All of the top five combinations included Acv that
reflects a reflex parasympathetic function. The other indices
including those in Cluster 3 are thought to reflect the tonic or
sustained level of parasympathetic function.
Fourth, the observation that mortality risk in patients without
low LVEF was best predicted by the combinations of indices in
Cluster 1 and 2 indicates an increased risk of the coexistence of
decreased HRV or HR responsiveness and increased abrupt large
HR changes. The λ25s reflects the fatness of tails of the probability
density function of the magnitude of abrupt large HR changes. Its
increase can occur when the relative frequency of large abrupt
HR changes to smaller HR changes increases, suggesting the
involvement of transient strong sympathetic activations (Kiyono
et al., 2008, 2012). The λ is increased in patients with heart
failure and the level of increase is associated with mortality
risk, while no other HRV or HR dynamics indices predict it
(Kiyono et al., 2007). The λ reflects the relative frequency of
large abrupt HR changes but does not depend on the magnitude
of HR change itself. Thus, this index could detect relative
sympathetic overactivity even under the situation of reduces
autonomic responsiveness.
Finally, the different predictive values of Cluster 2 predictor
(λ25s ) between patients with and without low LVEF may be
explained by the presence of overt or subclinical heart failure.
In patients with low LVEF, the prognostic value of the indices
of sympathetic overactivity could be less because sympathetic
nerve activity is increased by heart failure, which most of these
patients may have. In patients without low LVEF, the indices
of sympathetic overactivity could have greater predictive value
because it may reflect the presence or development of heart
failure in a part of these patients.
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Limitations
Among Cluster 1 predictors, Acv was the best univariate
predictor of post-AMI mortality, but this measure requires a
cyclic variation of HR associated with sleep apnea episodes.
Nevertheless, Acv was able to be calculated in all post-AMI
patients. This is because the Holter ECG data having sleep period
(time in bed) <3 h were not included in this study and because
Acv can be calculated even in patients with subclinical sleep
apnea if at least one episode of cyclic variation of HR is detected
during sleep. Assuming cases in which Acv cannot be calculated,
we examined logistic regression models excluding Acv, but the
results for the relationships between clusters and mortality risk
did not change (data not shown). Additionally, although study
participants were recruited from four different clinical sites in
diverse regions of the US, this study was performed using only
one cohort of post-AMI patients. To confirm the present findings,
future studies using different cohorts should be performed.

CONCLUSION
We investigated whether the survival predictors of HRV and
HR dynamics depend on LVEF after AMI. The mortality risk
in post-AMI patients with low LVEF is predicted by indices
that reflect decreased HRV or HR responsiveness and cardiac
parasympathetic dysfunction, whereas in patients without low
LVEF, the risk is predicted by a combination of predictors
reflecting decreased HRV or HR responsiveness and increased
abrupt large HR changes suggesting sympathetic involvement.
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